Details for Patent: 8,138,229
✉ Email this page to a colleague
Which drugs does patent 8,138,229 protect, and when does it expire?
Patent 8,138,229 protects ABRAXANE and is included in one NDA.
Protection for ABRAXANE has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.
This patent has forty-seven patent family members in twenty-one countries.
Summary for Patent: 8,138,229
Title: | Compositions and methods of delivery of pharmacological agents |
Abstract: | The present invention relates to a pharmaceutical composition comprising a pharmaceutical agent and a pharmaceutically acceptable carrier, which carrier comprises a protein, for example, human serum albumin and/or deferoxamine. He human serum albumin is present in an amount effective to reduce one or more side effects associated with administration of the pharmaceutical composition. The inventor also provides methods for reducing on or more side effects of administration of the pharmaceutical composition, and methods for enhancing transport and binding of a pharmaceutical agent to a cell. |
Inventor(s): | Desai; Neil P. (Los Angeles, CA), Soon-Shiong; Patrick (Los Angeles, CA), Trieu; Vuong (Calabasas, CA) |
Assignee: | Abraxis Bioscience, LLC (Los Angeles, CA) |
Application Number: | 12/910,693 |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 8,138,229 |
Patent Claim Types: see list of patent claims | Composition; Use; |
Drugs Protected by US Patent 8,138,229
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bristol-myers | ABRAXANE | paclitaxel | POWDER;INTRAVENOUS | 021660-001 | Jan 7, 2005 | AB | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,138,229
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Australia | 2003299590 | ⤷ Try a Trial | |||
Brazil | 0317134 | ⤷ Try a Trial | |||
Canada | 2509365 | ⤷ Try a Trial | |||
China | 102343094 | ⤷ Try a Trial | |||
China | 103405405 | ⤷ Try a Trial | |||
China | 104587479 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |